07/01/2025
5:09 AM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
4:20 PM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
4:30 PM | Kura Oncology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/03/2025
5:04 AM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
5:30 PM | FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:30 PM | Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
2:29 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kura Oncology (Subject)
| Form SCHEDULE 13G/A | |
05/02/2025
4:16 PM | Kura Oncology (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025
3:10 PM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
3:15 PM | Kura Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/17/2025
4:00 PM | Kura Oncology (Filer)
| Form ARS | |
Get the Latest News and Ratings for KURA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter. |
03/24/2025
3:33 PM | Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
3:21 PM | Hasnain Faheem (Reporting)
Kura Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
4:30 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kura Oncology (Subject)
| Form SCHEDULE 13G | |
02/14/2025
3:42 PM | Kura Oncology (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
7:15 PM | Kura Oncology (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
7:57 AM | Flynn James E (Filed by)
Kura Oncology (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
7:05 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
7:09 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
| Form SCHEDULE 13G | |
01/28/2025
7:54 PM | DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:36 PM | Kura Oncology (Subject)
Powl Brian T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
7:37 PM | Burrows Francis (Reporting)
Kura Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
7:37 PM | DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
7:37 PM | FORD KATHLEEN (Reporting)
Kura Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
7:37 PM | Bair Teresa Brophy (Reporting)
Kura Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
7:37 PM | Kura Oncology (Subject)
Leoni Mollie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
7:38 PM | Kura Oncology (Issuer)
Powl Brian T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:38 PM | Burrows Francis (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:38 PM | FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:38 PM | Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:39 PM | Kura Oncology (Issuer)
Leoni Mollie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:36 PM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
6:42 PM | BlackRock, Inc. (Filed by)
Kura Oncology (Subject)
| Form SCHEDULE 13G | |
01/07/2025
4:48 PM | Kura Oncology (Issuer)
Leoni Mollie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:42 PM | Kura Oncology (Issuer)
Leoni Mollie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
4:25 PM | Burrows Francis (Reporting)
Kura Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
4:32 PM | Burrows Francis (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:35 PM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
5:55 PM | Kura Oncology (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
11/20/2024
4:21 PM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:32 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
| Form SC 13G/A | |
Missed the Last 10,000% Surge? Here’s Your Next Chance (Ad) We’ve uncovered small-cap stocks that have delivered big wins—before the rest of the market caught on.
We don’t rely on luck—we rely on data, trends, and research. Our team is constantly scanning the market to spot hidden opportunities before they explode.
What if you could get alerts on high-potential companies—before the crowd? ➡️ Click here to get your free alerts. |
